Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1997-04-11 (29 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TEYRAN (34820), Herault
PHARMACIE ROQUE : revenue, balance sheet and financial ratios
PHARMACIE ROQUE is a French company
founded 29 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TEYRAN (34820),
this company of category PME
shows in 2022 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ROQUE (SIREN 411936982)
Indicator
2024
2023
2022
2021
2020
2017
2016
Revenue
N/C
N/C
2 282 669 €
N/C
N/C
1 557 643 €
1 554 833 €
Net income
38 576 €
25 190 €
42 366 €
44 755 €
34 406 €
79 384 €
26 571 €
EBITDA
N/C
N/C
58 830 €
N/C
N/C
67 183 €
17 233 €
Net margin
N/C
N/C
1.9%
N/C
N/C
5.1%
1.7%
Revenue and income statement
In 2024, PHARMACIE ROQUE generates positive net income of 39 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 27 k€ -> 39 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
38 576 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 45%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
44.783%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
37.348%
Solvency indicators evolution PHARMACIE ROQUE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2020
2021
2022
2023
2024
Debt ratio
472.045
75.124
0.388
18.02
57.998
54.594
44.783
Financial autonomy
10.415
31.236
36.491
40.466
31.283
34.013
37.348
Repayment capacity
7.291
0.972
None
None
2.478
None
None
Cash flow / Revenue
1.416%
4.291%
None%
None%
2.254%
None%
None%
Sector positioning
Debt ratio
44.782024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of PHARMACIE ROQUE (44.78) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
37.35%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+6 pts over 3 years
In 2024, the financial autonomy of PHARMACIE ROQUE (37.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
2.48 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE ROQUE (2.48) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ROQUE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2020
2021
2022
2023
2024
Operating WCR
153 695 €
154 316 €
0 €
0 €
-79 163 €
0 €
0 €
Inventory turnover (days)
42
40
0
0
0
0
0
Customer payment term (days)
3
4
0
0
0
0
0
Supplier payment term (days)
20
22
0
0
53
0
0
Positioning of PHARMACIE ROQUE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE ROQUE is estimated at
538 549 €
(range 375 037€ - 805 700€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
375k€538k€805k€
538 549 €Range: 375 037€ - 805 700€
NAF 5 année 2024
Valuation method used
Net Income Multiple
38 576 €
×
14.0x
=538 549 €
Range: 375 037€ - 805 701€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ROQUE with other companies in the same sector:
Yes, PHARMACIE ROQUE generated a net profit of 39 k€ in 2024.
Where is the headquarters of PHARMACIE ROQUE ?
The headquarters of PHARMACIE ROQUE is located in TEYRAN (34820), in the department Herault.
Where to find the tax return of PHARMACIE ROQUE ?
The tax return of PHARMACIE ROQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ROQUE operate?
PHARMACIE ROQUE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart